Goldman Sachs analyst Matthew Sykes double downgraded Cytek Biosciences (CTKB) to Sell from Buy with a price target of $4.50, down from $7. The ...
In a regulatory filing, Adobe (ADBE) disclosed that on January 24, Scott Belsky notified the company of his decision to resign as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback